与单纯化疗相比，明显治疗效果可被在使用信迪利单抗联合化疗治疗晚期非小细

Compared with chemotherapy alone, significant therapeutic effects can be obtained in the treatment of advanced non-small cell lung cancer with sintilimab combined with chemotherapy. With this combination treatment plan, serum tumor marker levels can be significantly reduced, the patient's cellular immune function can be improved, the total effective rate of treatment increases, and the risk of patient progression is reduced.

Compared with chemotherapy alone, the obvious therapeutic effect can be obtained in the treatment of advanced non-small cell lung cancer with Syndicated monoanti-anti-combination chemotherapy. With this combination therapy, serum tumor marker levels can be significantly reduced, patient cellular immune function can be improved, treatment efficiency is increased, and the risk of patient progression is reduced.

Compared with chemotherapy alone, cisplatin combined with small cell chemotherapy is more effective in the treatment of advanced lung cancer. With this combination therapy, the serum tumor marker level can be significantly reduced, the cellular immune function of patients can be improved, the total effective rate of treatment is increased, and the risk of patient progress is reduced.<br>